Статья

BOB.1 controls memory B-cell fate in the germinal center reaction

M. Levels, C. Fehres, B. van, U. van, K. Germar, T. O'Toole, I. Blijdorp, J. Semmelink, M. Doorenspleet, A. Bakker, M. Krasavin, A. Tomilin, S. Brouard, H. Spits, D. Baeten, N. Yeremenko,
2021

During T cell-dependent (TD) germinal center (GC) responses, naïve B cells are instructed to differentiate towards GC B cells (GCBC), high-affinity long-lived plasma cells (LLPC) or memory B cells (Bmem). Alterations in the B cell-fate choice could contribute to immune dysregulation leading to the loss of self-tolerance and the initiation of autoimmune disease. Here we show that mRNA levels of the transcription regulator BOB.1 are increased in the lymph node compartment of patients with rheumatoid arthritis (RA), a prototypical autoimmune disease caused by the loss of immunological tolerance. Investigating to what extent levels of BOB.1 impact B cells during TD immune responses we found that BOB.1 has a crucial role in determining the B cell-fate decision. High BOB.1 levels promote the generation of cells with phenotypic and functional characteristics of Bmem. Mechanistically, overexpression of BOB.1 drives ABF1 and suppresses BCL6, favouring Bmem over LLPC or recycling GCBC. Low levels of BOB.1 are sufficient for LLPC but not for Bmem differentiation. Our findings demonstrate a novel role for BOB.1 in B cells during TD GC responses and suggest that its dysregulation may contribute to the pathogenesis of RA by disturbing the B cell-fate determination. © 2019 The Authors

Цитирование

Похожие публикации

Документы

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • M. Levels
    Amsterdam UMC, University of Amsterdam, Department of Rheumatology & Clinical Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, Netherlands
  • C. Fehres
    Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam, Netherlands
  • B. van
    Amsterdam Rheumatology & Immunology Center (ARC), Amsterdam UMC, Netherlands
  • U. van
    Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, Netherlands
  • K. Germar
    AIMM Therapeutics, Amsterdam, Netherlands
  • T. O'Toole
    Saint Petersburg State University, Saint Petersburg, Russian Federation
  • I. Blijdorp
    Institute of Cytology, Russian Academy of Sciences, St-Petersburg, Russian Federation
  • J. Semmelink
    Centre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Université de Nantes, Nantes, France
  • M. Doorenspleet
  • A. Bakker
  • M. Krasavin
  • A. Tomilin
  • S. Brouard
  • H. Spits
  • D. Baeten
  • N. Yeremenko
Название журнала
  • Journal of Autoimmunity
Том
  • 101
Страницы
  • 131-144
Ключевые слова
  • CD40 ligand; chemokine receptor CXCR5; gamma interferon; interleukin 10; interleukin 17; interleukin 2; interleukin 21; interleukin 4; interleukin 5; interleukin 9; messenger RNA; biological marker; lymphocyte antigen receptor; POU2AF1 protein, human; transactivator protein; animal experiment; animal model; Article; CD4+ T lymphocyte; cell differentiation; cell fate; cell surface; clinical article; controlled study; flow cytometry; gene expression assay; gene overexpression; germinal center; human; human cell; immune response; immunological tolerance; memory cell; mouse; mRNA expression level; nonhuman; pathogenesis; peripheral blood mononuclear cell; priority journal; protein expression; real time polymerase chain reaction; rheumatoid arthritis; RNA extraction; stable expression; animal; B lymphocyte; cell line; gene expression; genetics; germinal center; immunological memory; immunology; knockout mouse; lymph node; metabolism; pathology; plasma cell; rheumatic fever; T lymphocyte; Animals; B-Lymphocytes; Biomarkers; Cell Line; Gene Expression; Germinal Center; Humans; Immunologic Memory; Lymph Nodes; Mice; Mice, Knockout; Plasma Cells; Receptors, Antigen, B-Cell; Rheumatic Fever; T-Lymphocytes; Trans-Activators
Издатель
  • Academic Press
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus